Phibro Animal Health reported $3M in Interest Expense on Debt for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Ani Pharmaceuticals ANIP:US $ 2.36M 324K
Bristol Myers Squibb BMY:US $ 357M 5M
Depomed DEPO:US $ 3.05M 1.45M
Eli Lilly And LLY:US $ 88.3M 4.2M
Endo International Ordinary Shares ENDP:US $ 135.83M 6.27M
Gw Pharmaceuticals GWPH:US $ 0.27M 0.03M
Henry Schein HSIC:US $ 10.49M 2.67M
Idexx Laboratories IDXX:US $ 9.49M 1.8M
JAZZ PHA JAZZ:US $ 28.93M 4.12M
Merk MRK:US $ 209M 3M
Pacira Pharmaceuticals PCRX:US $ 5.46M 0.57M
Teva Pharmaceutical Industries TEVA:US $ 241M 0M
Zoetis ZTS:US $ 58M 5M